Darvadstrocel
Darvadstrocel is a biological therapy with 7 clinical trials. Currently 1 active trials ongoing. Historical success rate of 66.7%.
Success Metrics
Based on 4 completed trials
Phase Distribution
Phase Distribution
0
Early Stage
0
Mid Stage
4
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
66.7%
4 of 6 finished
33.3%
2 ended early
1
trials recruiting
7
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
A Study of Darvadstrocel in Adults With Crohn's Disease and Complex Perianal Fistula
A Survey of Darvadstrocel in People With Crohn's Disease
A Study of Darvadstrocel for Treating Complex Perianal Fistulas in Children and Teenagers With Crohn's Disease
Long-term Follow-up Study With Darvadstrocel in the Treatment of Complex Perianal Fistula
Phase 3 Study of Cx601 in Participants With Complex Perianal Fistulising Crohn's Disease
Clinical Trials (7)
A Study of Darvadstrocel in Adults With Crohn's Disease and Complex Perianal Fistula
A Survey of Darvadstrocel in People With Crohn's Disease
A Study of Darvadstrocel for Treating Complex Perianal Fistulas in Children and Teenagers With Crohn's Disease
Long-term Follow-up Study With Darvadstrocel in the Treatment of Complex Perianal Fistula
Phase 3 Study of Cx601 in Participants With Complex Perianal Fistulising Crohn's Disease
Darvadstrocel for Crohn's Fistula in the Realworld
Efficacy of Cx601 (Darvadstrocel) for the Treatment of Perianal Fistulizing Crohn's Disease
All 7 trials loaded
Drug Details
- Intervention Type
- BIOLOGICAL
- Total Trials
- 7